Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
06/17/1992 | CN1061971A Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
06/17/1992 | CN1061962A Indenoindole compounds |
06/16/1992 | US5122603 Purified insulin mediators and purification process for same |
06/16/1992 | US5122596 Polypeptides useful as blockers of calcium channels |
06/16/1992 | US5122537 Tyrosine kinase inhibitors |
06/16/1992 | US5122374 Pharmaceutical product having epidermal regenerative activity based on the active ingredient of mimosa tenuiflora and process for its obtention |
06/16/1992 | CA1303627C Nona and decapeptide analogs of lhrh useful as lhrh antagonists |
06/16/1992 | CA1303616C N-1-azabicyclo¬2,2,2|-oct-3yl)-benzamide compounds |
06/16/1992 | CA1303504C Pharmaceutical formulation containing acrivastine |
06/15/1992 | CA2057511A1 Biphenylyl compounds |
06/14/1992 | WO1992010494A1 Pharmaceuticals |
06/14/1992 | WO1992010190A1 Novel csaids |
06/14/1992 | CA2098309A1 Pharmaceuticals |
06/14/1992 | CA2098177A1 Csaids |
06/12/1992 | WO1992010476A1 N-substituted lactams useful as cholecystokinin antagonists |
06/12/1992 | CA2097517A1 N-substituted lactams useful as cholecystokinin antagonists |
06/11/1992 | WO1992009697A1 USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-β FOR BONE REPAIR |
06/11/1992 | WO1992009626A1 Nonapeptide bombesin antagonists |
06/11/1992 | WO1992009619A1 2β,19-METHYLENEAMINO BRIDGED STEROIDS AS AROMATASE INHIBITORS |
06/11/1992 | WO1992009600A1 Benzofuran and benzthiophene derivatives |
06/11/1992 | WO1992009567A1 Anti-inflammatory compounds |
06/11/1992 | WO1992009566A1 Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
06/11/1992 | WO1992009304A1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
06/11/1992 | WO1992009301A1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
06/11/1992 | WO1992009297A1 Hiv protease inhibitors |
06/11/1992 | WO1992009293A1 Inhibition of cell adhesion protein-carbohydrate interactions |
06/11/1992 | WO1992009282A1 Treatment for tissue ulceration |
06/11/1992 | WO1992009278A1 Substituted 5-aryl imidazoles |
06/11/1992 | WO1992007832A3 Substituted piperazines as central nervous system agents |
06/11/1992 | DE4038947A1 Dithiolano- und dithianoglycin-haltige renininhibitorische peptide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Dithiolano- and dithianoglycin-containing peptide renininhibitorische, process for their production and their use in medicinal products |
06/11/1992 | DE4038921A1 Renininhibitorische peptide vom cyclohexylstatin-typ, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Renininhibitorische peptide from cyclohexylstatin-type, process for their production and their use in medicinal products |
06/11/1992 | CA2097617A1 Inhibition of cell adhesion protein-carbohydrate interactions |
06/10/1992 | EP0489663A1 Thiazolidine-2,4-dione compound, method for production thereof, and medicine containing the compound for cure diabetic complications |
06/10/1992 | EP0489616A1 Use in anaesthesia and pharmaceutical compositions of (R)-isoflurane and (R)-desflurane |
06/10/1992 | EP0489579A1 Peptidyl derivatives |
06/10/1992 | EP0489577A1 Peptidyl derivatives |
06/10/1992 | EP0489547A1 A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof |
06/10/1992 | EP0489178A1 Antitumor agent |
06/10/1992 | EP0489058A1 Cystic fibrosis gene |
06/10/1992 | CN1061778A Aminodiol derivatives |
06/10/1992 | CN1061775A Hydroxamic acid and n-hydroxyurea derivatives and their use |
06/09/1992 | US5120870 Emulsion of lipid containing a prostaglandin analogue |
06/09/1992 | US5120850 Process for the preparation of morphologically homogeneous forms of thiazole derivatives |
06/09/1992 | US5120831 Metal-peptide compositions |
06/09/1992 | US5120830 Anticoagulant |
06/09/1992 | US5120764 Administering penicillamine and allenylamines to inhibit crosslinking of collagen |
06/09/1992 | US5120752 Cyclopropyl derivative lipoxygenase inhibitors |
06/09/1992 | US5120744 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
06/09/1992 | US5120743 Cyclic anthranilic acid acetic acid derivatives and process for the preparation |
06/09/1992 | US5120740 Targeting antitumor drugs to kidneys |
06/09/1992 | US5120729 Beta-lactams as antihypercholesterolemics |
06/09/1992 | US5120719 Conjugate of prostaglandin and polysaccharide |
06/09/1992 | US5120647 Phospholipase a2 inhibitor |
06/09/1992 | US5120527 Paramagnetic oil emulsions as mri contrast agents |
06/09/1992 | CA1303294C .alpha.-HYDROXY THIOETHERS |
06/09/1992 | CA1303057C P-aminophenols, derivatives thereof and method of use |
06/09/1992 | CA1303049C 3-(1h-tetrazol-5-yl)oxanilic acid and salts thereof, method for preparing the same and pharmaceutical compositions containing the compound |
06/09/1992 | CA1303045C Selective inhibitors for benzylaminoxidases with respect to other aminoxidases |
06/09/1992 | CA1303044C Benzhydryloxyethylpiperidine derivatives process for their preparation and pharmaceutical compositions in which they are present |
06/09/1992 | CA1303038C Diselenobis benzoic acid amides of primary heterocyclic amines, process for producing the same and pharmaceutical compounds comprisingthe same |
06/09/1992 | CA1303025C 17-.beta. A-OH 19-NORSTEROIDS SUBSTITUTED IN 17A, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
06/09/1992 | CA1302880C Agents for the treatment of arthroses |
06/09/1992 | CA1302879C Composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine |
06/08/1992 | WO1992010504A2 Phosphonic acid derivatives useful as antiinflammatory agents |
06/08/1992 | CA2094123A1 Phosphonic acid derivatives useful as antiinflammatory agents |
06/08/1992 | CA2057157A1 Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections |
06/08/1992 | CA2057089A1 Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists |
06/08/1992 | CA2056967A1 Use of organic compounds |
06/08/1992 | CA2056957A1 Nutrition |
06/08/1992 | CA2056809A1 Benzodiazepine analogs |
06/06/1992 | WO1992010173A1 Pharmaceutical compositions |
06/06/1992 | CA2097495A1 Pharmaceutical compositions |
06/04/1992 | WO1992009616A1 Enhancement of musculature in animals |
06/04/1992 | WO1992009565A1 Peptidyl derivatives |
06/04/1992 | WO1992009564A1 Peptidyl derivatives |
06/04/1992 | CA2097590A1 Enhancement of musculature in animals |
06/04/1992 | CA2073513A1 Peptidyl derivatives |
06/04/1992 | CA2073510A1 Peptidyl derivatives |
06/03/1992 | EP0488979A1 Novel inhibitory peptides |
06/03/1992 | EP0488401A1 A controlled-release pharmaceutical preparation for intra-ocular implant |
06/03/1992 | EP0488383A1 2-beta,19-ethylene bridged steroids as aromatase inhibitors |
06/03/1992 | EP0488209A1 Process for producing benzylphthalazinone derivatives and salts thereof |
06/03/1992 | EP0488196A2 HST-2, a member of the heparin binding growth factor family |
06/03/1992 | EP0488059A2 Use of a combination of an ace inhibitor with a calcium antagonist in the treatment of proteinuria |
06/03/1992 | EP0487980A1 Aminodiols-derivatives |
06/03/1992 | EP0487627A1 Wound healing preparations containing heparanase |
06/03/1992 | EP0487617A1 Synthetic peptides that enhance cell binding. |
06/03/1992 | CN1061594A Hydroxyalkylquineline ether acids as leakotaiene antagonists |
06/02/1992 | US5118882 Streptenols from streptomycetes, and the preparation and use thereof |
06/02/1992 | US5118806 Enzyme inhibitor for lipoxygenase; useful for treating cancer, hepatic diseases, inflammation, cerebrovascular diseases |
06/02/1992 | US5118701 Antiischemic agents, anticoagulants |
06/02/1992 | US5118700 Indole derivatives and compositions for their use in medicaments |
06/02/1992 | US5118684 Piperdine derivative and pharmaceutical composition |
06/02/1992 | US5118667 Bone growth factors and inhibitors of bone resorption for promoting bone formation |
06/02/1992 | CA1302425C Prodrugs of antihypercholesterolemic compounds |
06/02/1992 | CA1302424C Phenolic thioethers as inhibitors of 5-lipoxygenase |
06/02/1992 | CA1302421C 3-aryloxy-3-substituted propanamines |
06/02/1992 | CA1302418C 3,5-disubstituted pyrocatechole derivatives |
06/02/1992 | CA1302405C Ergoline derivatives |
06/02/1992 | CA1302268C Pharmaceutical compositions containing diltiazem and an enzyme inhibitor |